These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22372703)

  • 21. Accessing the accelerated approval pathway for rare disease therapeutics.
    Kakkis ED; Kowalcyk S; Bronstein MG
    Nat Biotechnol; 2016 Apr; 34(4):380-3. PubMed ID: 27054988
    [No Abstract]   [Full Text] [Related]  

  • 22. Regulators adopt more orphan drugs.
    Reardon S
    Nature; 2014 Apr; 508(7494):16-7. PubMed ID: 24695293
    [No Abstract]   [Full Text] [Related]  

  • 23. Canadian and US drug approval times and safety considerations.
    Rawson NS; Kaitin KI
    Ann Pharmacother; 2003 Oct; 37(10):1403-8. PubMed ID: 14519031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The FDA Breakthrough-Drug Designation - Four Years of Experience.
    Darrow JJ; Avorn J; Kesselheim AS
    N Engl J Med; 2018 Apr; 378(15):1444-1453. PubMed ID: 29641970
    [No Abstract]   [Full Text] [Related]  

  • 25. Urgent need for new drugs in sub-Saharan Africa, says WMA president.
    S Afr Med J; 2004 Apr; 94(4):255. PubMed ID: 15154389
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical approval success rates for investigational cancer drugs.
    DiMasi JA; Reichert JM; Feldman L; Malins A
    Clin Pharmacol Ther; 2013 Sep; 94(3):329-35. PubMed ID: 23739536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New drug approvals for 2002.
    Frantz S; Smith A
    Nat Rev Drug Discov; 2003 Feb; 2(2):95-6. PubMed ID: 12572538
    [No Abstract]   [Full Text] [Related]  

  • 28. The numbers game.
    Nat Rev Drug Discov; 2002 Dec; 1(12):929. PubMed ID: 12474850
    [No Abstract]   [Full Text] [Related]  

  • 29. Competitive Development in Pharmacologic Classes: Market Entry and the Timing of Development.
    DiMasi JA; Chakravarthy R
    Clin Pharmacol Ther; 2016 Dec; 100(6):754-760. PubMed ID: 27617627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2004 approvals: the demise of the blockbuster?
    Frantz S
    Nat Rev Drug Discov; 2005 Feb; 4(2):93-4. PubMed ID: 15756752
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug launch curves in the modern era.
    Robey S; David FS
    Nat Rev Drug Discov; 2017 Jan; 16(1):13-14. PubMed ID: 27910876
    [No Abstract]   [Full Text] [Related]  

  • 32. Approval times and the safety of new pharmaceuticals.
    Rudholm N
    Eur J Health Econ; 2004 Dec; 5(4):345-50. PubMed ID: 15452739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing Specialty Drug Use.
    American College of Clinical Pharmacy
    Pharmacotherapy; 2017 Aug; 37(8):973-975. PubMed ID: 28585720
    [No Abstract]   [Full Text] [Related]  

  • 34. Raising the game.
    Nat Biotechnol; 2008 Feb; 26(2):137. PubMed ID: 18259155
    [No Abstract]   [Full Text] [Related]  

  • 35. New biotechnology approvals for 2002.
    Piascik P
    J Am Pharm Assoc (Wash); 2003; 43(1):116-7. PubMed ID: 12585761
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical Drug Innovation From 2000 Through 2014.
    Walter JR; Xu S
    JAMA Dermatol; 2015 Jul; 151(7):792-4. PubMed ID: 25807060
    [No Abstract]   [Full Text] [Related]  

  • 37. Approval of new drugs for glioblastoma.
    Weller M; Stupp R
    Curr Opin Neurol; 2009 Dec; 22(6):617-8. PubMed ID: 19770759
    [No Abstract]   [Full Text] [Related]  

  • 38. Making medical progress. A look at FDA approvals in 2000.
    FDA Consum; 2001; 35(2):7-8. PubMed ID: 11444251
    [No Abstract]   [Full Text] [Related]  

  • 39. 2013 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2014 Feb; 13(2):85-9. PubMed ID: 24481294
    [No Abstract]   [Full Text] [Related]  

  • 40. Number of agents being developed to combat drug resistant bacteria is "alarmingly low," warns report.
    McCarthy M
    BMJ; 2013 Apr; 346():f2548. PubMed ID: 23604164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.